Stocktoria
HARVARD BIOSCIENCE INC HBIO
HARVARD BIOSCIENCE INC financials (annual)
Bars are annual figures from 2017 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $86.5M | — | $94.1M | $112.2M | $113.3M | $118.9M | $102.1M | $116.2M | $120.8M | $77.4M |
| Gross profit | $49.9M | — | $54.8M | $66.1M | $60.8M | $67.7M | $58.0M | $64.3M | $63.2M | $39.2M |
| R&D expense | $8.8M | — | $10.4M | $11.8M | $12.3M | $10.8M | $8.7M | $10.7M | $11.0M | $5.6M |
| Operating income | -$48.6M | — | -$6.2M | $1.9M | -$6.9M | $2.1M | $221,000 | $377,000 | $984,000 | -$635,000 |
| Interest expense | — | — | — | — | — | — | — | — | $5.4M | $713,000 |
| Income tax | -$686,000 | — | $740,000 | $859,000 | $337,000 | $148,000 | $518,000 | -$815,000 | -$3.7M | -$605,000 |
| Net income | -$56.7M | -$12.4M | -$12.4M | -$3.4M | -$9.5M | -$288,000 | -$7.8M | -$4.7M | -$2.9M | -$865,000 |
| EPS (diluted) | $-1.28 | — | $-0.28 | $-0.08 | $-0.23 | — | — | $-0.12 | $-0.08 | $-0.02 |
| Operating cash flow | $6.7M | — | $1.4M | $14.0M | $1.2M | $1.3M | $9.3M | $8.0M | $2.9M | $1.1M |
| Free cash flow | $5.5M | — | -$1.2M | $12.2M | -$438,000 | $67,000 | $8.2M | $6.8M | $1.9M | $167,000 |
| Cash & equivalents | $8.6M | $6.8M | $4.1M | $4.3M | $4.5M | $7.8M | $8.3M | $8.3M | $8.2M | $5.7M |
| Inventory | $20.8M | $21.6M | $23.2M | $24.7M | $26.4M | $27.6M | $22.3M | $22.1M | $25.1M | $16.8M |
| Total assets | $80.1M | $78.0M | $126.6M | $137.4M | $145.4M | $162.3M | $156.3M | $164.9M | $168.6M | $109.4M |
| Total liabilities | $66.3M | $63.9M | $63.3M | $64.3M | $73.1M | $78.9M | $79.6M | $83.2M | $85.9M | $28.5M |
| Shareholders' equity | $13.7M | $14.1M | $63.3M | $73.1M | $72.2M | $83.4M | $76.7M | $81.7M | $82.7M | $80.9M |
Growth · year-over-year · Revenue CAGR 1.4%
| Metric | FY2025 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | — | — | -16.1% | -1.0% | -4.7% | +16.5% | -12.1% | -3.8% | +56.0% | -25.9% |
| Free cash flow growth | — | — | -109.8% | — | -753.7% | -99.2% | +19.8% | +259.8% | +1036.5% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.